AEON Biopharma, Inc. Class A (AEON)
AMEX · Healthcare
$0.29-2.03%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $3.45M
- P/E ratio
- —
- EPS
- —
- Volume
- 549,999
- 52-week high
- —
- 52-week low
- —
- Open
- $0.28
- Day high
- $0.30
- Day low
- $0.28
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$39.22M | -$3.95 |
| 2024 | — | $42.01M | $72.93 |
| 2023 | — | -$60.68M | -$0.44 |
| 2022 | — | -$52.56M | -$0.38 |
| 2021 | — | $8.2M | — |
About AEON Biopharma, Inc. Class A
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
- CEO
- Robert Bancroft
- Employees
- 8
- Country
- US
- IPO date
- Jul 24, 2023
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is AEON Biopharma, Inc. Class A's stock price today?
- AEON is trading at $0.29 as of Jul 20, 2026.
- What is AEON Biopharma, Inc. Class A's market cap?
- AEON Biopharma, Inc. Class A (AEON) has a market capitalization of $3.45M.
- Does AEON Biopharma, Inc. Class A pay a dividend?
- AEON Biopharma, Inc. Class A did not pay a dividend in its most recent reported fiscal year.
- What sector is AEON Biopharma, Inc. Class A in?
- AEON Biopharma, Inc. Class A operates in the Healthcare sector.